Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_provenance.
- NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_assertion description "[Analysis of 209 neuroblastoma patient tumors revealed that, in contrast with ABCC1 and ABCC4, low rather than high ABCC3 expression was associated with reduced event-free survival (HR of recurrence or death = 2.4, 95% CI = 1.4 to 4.2; P = .001), with 23 of 53 patients with low ABCC3 expression experiencing recurrence or death compared with 31 of 155 patients with high ABCC3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_provenance.
- NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_assertion evidence source_evidence_literature NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_provenance.
- NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_assertion SIO_000772 21799180 NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_provenance.
- NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_assertion wasDerivedFrom befree-20140225 NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_provenance.
- NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_assertion wasGeneratedBy ECO_0000203 NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP319353.RA0M2gy_boEORdN5CIK9_xFm_me7X790eBatgLgpJLKqE130_provenance.